1) gliquidone
格列喹酮
1.
Preparation and Dissolution Rate of Gliquidone Solid Dispersion;
格列喹酮固体分散体的制备及溶出度测定
2.
Prescription and Process of Dispersible Gliquidone Tablets;
格列喹酮分散片处方工艺研究
3.
Preparation of gliquidone tablet and determination of its dissolution;
格列喹酮片的处方考查及溶出度测定
2) Gliquidone
格列喹酮片
1.
Pharmacokinetics and Relative Bioavailability of Gliquidone Tablet in Volunteers;
格列喹酮片人体药动学及生物等效性研究
3) gliquidone dispersibe tablet
格列喹酮分散片
4) Gliquidone Capsules
格列喹酮胶囊
5) rosiglitazone
罗格列酮
1.
Effect of rosiglitazone on pulmonary inflammation in streptozocin-induced diabetic rats;
罗格列酮对糖尿病大鼠肺炎性病变的影响
2.
Experimental study on the protective effects of rosiglitazone on aortic endothelial cells of spontaneously type 2 diabetic rats;
罗格列酮对自发性2型糖尿病大鼠主动脉内皮细胞保护作用的实验研究
3.
The anti-hypertensive effect of insulin sensitizer rosiglitazone in two sorts of hypertensive rat;
罗格列酮对2种高血压大鼠的降压作用及机制
6) troglitazone
曲格列酮
1.
Influence of troglitazone on proliferation of human liver cancer cell line HepG2 in vitro and on β-catenin signaling pathway;
曲格列酮体外对肝癌细胞HepG2生长及β-catenin信号通路的影响
2.
Troglitazone induces gastric cancer cell line MKN45 apoptosis;
曲格列酮诱导胃癌MKN45细胞株凋亡
3.
Effects of troglitazone on proliferation and differentiation of human preadipocytes;
曲格列酮对人前脂肪细胞增殖和分化的影响
补充资料：格列喹酮
分子式：C27H33N3O6S
分子量：暂无
CAS号：33342-05-1
性质：暂无
制备方法：暂无
用途：降血糖药，用于非胰岛素依赖型糖尿病药。
分子量：暂无
CAS号：33342-05-1
性质：暂无
制备方法：暂无
用途：降血糖药，用于非胰岛素依赖型糖尿病药。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条